Chagas heart disease is common in Latin America. Now, given the growing immigrant population, U.S. physicians need to know how to recognize and treat it. 

An increase in the change in abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) volume was associated with an increased incidence of cardiovascular disease risk factors, according to an analysis of a long-term prospective study.

Harry Selker, MD, a cardiologist, is talking with the FDA about conducting a trial to test the effectiveness of glucagon, insulin and potassium (GIK) in acute coronary emergencies, NPR reports.

The benefits of drinking tea may extend to improving cardiovascular health. After adjusting for multiple variables, adults who drank at least one cup of tea per day had a slower progression of coronary artery calcium and 29 percent lower incidence of cardiovascular events compared with adults who never drank tea.

A survey of clinicians in Michigan found no consensus about whether cardiologists or primary care physicians should be responsible for bridging anticoagulation management in patients with atrial fibrillation who must temporarily discontinue warfarin before undergoing a colonoscopy.

In an effort to find solutions to problems in healthcare using tech, the American Heart Association (AHA) has launched the Center for Health Technology & Innovation.

An evidence review of 39 clinical trials found that patients who received continuous long-term treatment with colchicine had no reduction in all-cause mortality or cardiovascular mortality.

Two post-hoc analyses of a clinical trial found that patients with heart failure who received sacubitril/valsartan (Entresto) had lower reductions in health-related quality of life and lower risks of cardiovascular death and heart failure hospitalization.